Eugenosedin-A based pharmacoligical agents
US7105521B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 30, 2003 |
| Grant date | Sep 12, 2006 |
| Priority date | — |
| Expiry date | Jun 30, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/495
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides isoeugenol derivative compounds having the moietyand having α2-adrenergic/5-HT2A antagonist, 5-HT re-uptake inhibition, and anti-oxidant activities.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.